FDA Litigation Updates: Navigating Post-Chevron and a New Administration

Public Policy & Regulation attorney Rachel Gartner will be a featured speaker during a webinar hosted by the American Health Law Association (AHLA) analyzing litigation trends surrounding U.S. Food and Drug Administration (FDA)-regulated products. She will discuss the ongoing effects of the U.S. Supreme Court's Loper Bright decision overturning Chevron deference in addition to potential challenges and opportunities for companies under the Trump Administration. Participants will hear insights on what to consider when marketing an FDA-regulated product and how to resolve disputes with the FDA, what recent FDA warning letters and enforcement actions mean for the industry, and what priorities and policies could emerge under the new administration.